X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Aventis Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ADCOCK INGRAM (S. Africa) - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ADCOCK INGRAM
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ADCOCK INGRAM
Jun-14
SANOFI INDIA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs6,840357-   
Low Rs4,630258-   
Sales per share (Unadj.) Rs1,203.1106.3-  
Earnings per share (Unadj.) Rs165.3-26.8-  
Cash flow per share (Unadj.) Rs209.9-22.2-  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.683.5-  
Shares outstanding (eoy) m23.03168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.82.9 164.7%   
Avg P/E ratio x34.7-11.5 -302.2%  
P/CF ratio (eoy) x27.3-13.9 -197.2%  
Price / Book Value ratio x6.03.7 161.5%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,07851,922 254.4%   
No. of employees `0003.34.3 76.9%   
Total wages/salary Rs m4,0683,259 124.8%   
Avg. sales/employee Rs Th8,393.84,180.1 200.8%   
Avg. wages/employee Rs Th1,232.4759.1 162.3%   
Avg. net profit/employee Rs Th1,153.0-1,053.3 -109.5%   
INCOME DATA
Net Sales Rs m27,70817,945 154.4%  
Other income Rs m897126 713.8%   
Total revenues Rs m28,60518,071 158.3%   
Gross profit Rs m6,235-3,110 -200.5%  
Depreciation Rs m1,027775 132.6%   
Interest Rs m7486 1.4%   
Profit before tax Rs m6,098-4,245 -143.7%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292265 864.1%   
Profit after tax Rs m3,806-4,522 -84.2%  
Gross profit margin %22.5-17.3 -129.9%  
Effective tax rate %37.6-6.2 -601.5%   
Net profit margin %13.7-25.2 -54.5%  
BALANCE SHEET DATA
Current assets Rs m15,92213,143 121.1%   
Current liabilities Rs m6,2357,395 84.3%   
Net working cap to sales %35.032.0 109.1%  
Current ratio x2.61.8 143.7%  
Inventory Days Days64111 57.4%  
Debtors Days Days21124 16.8%  
Net fixed assets Rs m7,5397,661 98.4%   
Share capital Rs m23083 276.1%   
"Free" reserves Rs m21,9620-   
Net worth Rs m22,19214,085 157.6%   
Long term debt Rs m04,950 0.0%   
Total assets Rs m29,83926,608 112.1%  
Interest coverage x872.1-7.7 -11,279.3%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 137.7%   
Return on assets %12.8-15.2 -84.3%  
Return on equity %17.2-32.1 -53.4%  
Return on capital %27.5-19.8 -138.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4420-   
CASH FLOW
From Operations Rs m3,7391,532 244.1%  
From Investments Rs m-731-470 155.4%  
From Financial Activity Rs m-1,9724,492 -43.9%  
Net Cashflow Rs m1,0365,554 18.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.93 Rs / ZAR

Compare SANOFI INDIA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  IPCA LABS  



Today's Market

Sensex Ends 234 Points Higher; Healthcare and Realty Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets witnessed buying interest during closing hours and ended higher.

Related Views On News

PROCTER & GAMBLE HEALTH at All Time High; BSE HEALTHCARE Index Up 0.9% (Market Updates)

Jul 16, 2019 | Updated on Jul 16, 2019

PROCTER & GAMBLE HEALTH share price has hit an all time high at Rs 4,768 (up 9.3%). The BSE HEALTHCARE Index is up by 0.9%. Among the top gainers in the BSE HEALTHCARE Index today are PROCTER & GAMBLE HEALTH (up 9.3%) and SANOFI INDIA (up 0.5%). The top losers include BLISS GVS PHARMA (down 0.2%) and NARAYANA HRUDAYALAYA LTD (down 0.2%).

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today (Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance (The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jul 16, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS